-
公开(公告)号:US10076427B2
公开(公告)日:2018-09-18
申请号:US15431311
申请日:2017-02-13
Applicant: Neograft Technologies, Inc.
Inventor: Lorenzo Soletti , Mohammed S. El-Kurdi , Jon McGrath , J. Christopher Flaherty
CPC classification number: A61F2/82 , A61B17/11 , A61B17/122 , A61B2017/00252 , A61B2017/00969 , A61B2017/1107 , A61B2017/1135 , A61F2/06 , A61F2/064 , A61F2210/0076 , A61L27/44 , A61L27/507 , A61L27/56
Abstract: In some aspects, graft devices for a mammalian patient can include a tubular member comprising a first end; and a fiber matrix surrounding the tubular member, wherein the fiber matrix is designed and constructed to be substantially continuously tapered at the first end to define a diameter that increases as it approaches the first end.
-
公开(公告)号:US20170312100A1
公开(公告)日:2017-11-02
申请号:US15431311
申请日:2017-02-13
Applicant: Neograft Technologies, Inc.
Inventor: Lorenzo SOLETTI , Mohammed S. EL-KURDI , Jon MCGRATH , J. Christopher FLAHERTY
CPC classification number: A61F2/82 , A61B17/11 , A61B17/122 , A61B2017/00252 , A61B2017/00969 , A61B2017/1107 , A61B2017/1135 , A61F2/06 , A61F2/064 , A61F2210/0076 , A61L27/44 , A61L27/507 , A61L27/56
Abstract: In some aspects, graft devices for a mammalian patient can include a tubular member comprising a first end; and a fiber matrix surrounding the tubular member, wherein the fiber matrix is designed and constructed to be substantially continuously tapered at the first end to define a diameter that increases as it approaches the first end.
-
3.
公开(公告)号:US20160302911A1
公开(公告)日:2016-10-20
申请号:US15108276
申请日:2014-12-22
Applicant: NEOGRAFT TECHNOLOGIES, INC.
Inventor: Lorenzo SOLETTI
CPC classification number: A61F2/06 , A61F2/062 , A61F2/064 , A61F2210/0004 , A61F2250/0019 , A61F2250/003 , A61F2250/0067 , A61L27/18 , A61L27/28 , A61L27/50 , A61L27/54 , A61L27/56 , A61L27/58 , A61L2300/42 , A61L2420/08 , A61L2430/36 , C08L67/04
Abstract: In some aspects, a graft device can include a biodegradable inner layer, an outer layer, a first end portion, a second end portion, and a lumen therebetween. The biodegradable inner layer typically includes an inner surface and an outer surface. The outer layer typically includes a fiber matrix surrounding the outer surface of the inner layer. The graft device can include a reinforced end portion. At least 10% or at least 50% of the graft device can remain after 90 days of implantation. In some cases, at least 10% or at least 50% of the graft device can remain after 180 days of implantation. The graft device can include a kink-resisting element. The graft device can include at least one layer with a dynamic compliance less than or equal to at least one of: 20%/100 mmHg or 5%/100 mmHg.
Abstract translation: 在一些方面,移植装置可以包括可生物降解的内层,外层,第一端部,第二端部和其间的内腔。 可生物降解内层通常包括内表面和外表面。 外层通常包括围绕内层的外表面的纤维基质。 移植装置可以包括加强的端部。 移植装置的至少10%或至少50%可以在植入90天后保留。 在一些情况下,移植装置的至少10%或至少50%可以在植入180天后保留。 移植装置可以包括抗皱元件。 移植装置可包括至少一层具有小于或等于20%/ 100mmHg或5%/ 100mmHg中至少之一的动态顺应性的层。
-
4.
公开(公告)号:US20140332164A1
公开(公告)日:2014-11-13
申请号:US14364989
申请日:2012-12-12
Applicant: Neograft Technologies, Inc.
Inventor: Lorenzo Soletti , Mohammed S. El-Kurdi , Jon McGrath , J. Christopher Flaherty
IPC: A61F2/06
CPC classification number: A61F2/062 , A61F2/06 , B05D1/007 , B05D1/42 , B29C47/0023 , B29C47/908 , B29C65/48 , B29C66/5221 , B32B1/08 , D01D5/0084 , D04H1/728 , D04H1/76 , D04H3/073
Abstract: In some aspects, a system for applying a fiber matrix on a tubular conduit is provided. The system can include a tubular conduit, a mandrel and a fiber matrix delivery assembly. The mandrel can comprise an elongate shaft and a rolling membrane configured to atraumatically engage the tubular conduit.
Abstract translation: 在一些方面,提供了一种在管状导管上施加纤维基质的系统。 该系统可以包括管状导管,心轴和纤维矩阵输送组件。 心轴可以包括细长轴和构造成与管状导管无接触地接合的滚动膜。
-
公开(公告)号:US20210196445A1
公开(公告)日:2021-07-01
申请号:US17058776
申请日:2019-06-07
Applicant: NEOGRAFT TECHNOLOGIES, INC.
Inventor: Mohammed El-Kurdi , Ayotte Ryan , Anh Thi Dinh , Kevin Farrell , Jon McGrath
IPC: A61F2/06
Abstract: Provided herein our graft devices for a patient comprising one or more layers, such as an inner layer and an outer layer. The inner layer comprises a first porous arrangement of fibers defining a first tube comprising an inner wall and an outer wall. The outer layer comprises a second porous arrangement of fibers defining a second tube comprising an inner wall and an outer wall. The second tube surrounds the first tube. A plurality of macropores extend through at least the inner and outer wall of the first tube. The inner and/or the outer layer can comprise a biofragmentable material configured to mechanically fracture into one or more fragments over time. Methods of creating graft devices are also disclosed.
-
公开(公告)号:US20170296192A1
公开(公告)日:2017-10-19
申请号:US15344998
申请日:2016-11-07
Applicant: NEOGRAFT TECHNOLOGIES, INC.
Inventor: Peter P. ZILLA , Nasser RAFIEE , Deon BEZUIDENHOUT , Thomas FRANZ , Mark YEOMAN , Hellmut C. BOWLES , Nareak DOUK , Michael F. WOLF , Paul HUMAN
CPC classification number: A61B17/11 , A61B5/1076 , A61B2017/1107 , A61B2017/1132 , A61B2017/1135 , A61B2017/1139 , A61F2/06 , A61F2/07 , A61F2/82 , A61F2/856 , A61F2/90 , A61F2/95 , A61F2240/002
Abstract: Stents and methods of using stents are provided. Stents of the invention provide external support structure for a blood vessel segment disposed within, wherein the stents are capable of resilient radial expansion in a manner mimicking the compliance properties of an artery. The stent may be formed of a knitted or braided mesh formed so as to provide the needed compliance properties. A venous graft with the stent and a vein segment disposed within is provided, wherein graft is capable of mimicking the compliance properties of an artery. Methods of selecting stents for downsizing and methods of using the stents of the invention in downsizing and smoothening are provided. Methods of replacing a section of an artery with a venous graft including a stent of the invention are provided. Methods of reducing intimal hyperplasia in implanted vein segment in a venous graft using stents of the invention are provided.
-
公开(公告)号:US20160287374A1
公开(公告)日:2016-10-06
申请号:US15036304
申请日:2014-11-14
Applicant: NEOGRAFT TECHNOLOGIES, INC.
Inventor: Lorenzo SOLETTI , Cory LEESON , Jon MCGRATH , Matthew MANNARINO , John SPIRIDIGLIOZZI
CPC classification number: A61F2/07 , A61F2/04 , A61F2/06 , A61F2/88 , A61F2002/825 , A61F2210/0014 , A61F2210/0076 , A61F2240/002 , A61L27/34 , A61L27/507 , A61L2420/02 , A61L2420/06
Abstract: A graft device for a mammalian patient comprises a tubular conduit and a fiber matrix surrounding the tubular conduit. The fiber matrix can comprise one or more polymers delivered by an electrospinning device. Systems and methods of creating a graft device are also provided.
Abstract translation: 用于哺乳动物患者的移植装置包括管状导管和围绕管状导管的纤维基质。 纤维基质可以包含一种或多种由静电纺丝装置递送的聚合物。 还提供了创建移植装置的系统和方法。
-
公开(公告)号:US20150202063A1
公开(公告)日:2015-07-23
申请号:US14586419
申请日:2014-12-30
Applicant: Neograft Technologies, Inc.
Inventor: Lorenzo Soletti , Mohammed S. El-Kurdi , Jon McGrath , J. Christopher Flaherty
IPC: A61F2/82
CPC classification number: A61F2/82 , A61B17/11 , A61B17/122 , A61B2017/00252 , A61B2017/00969 , A61B2017/1107 , A61B2017/1135 , A61F2/06 , A61F2/064 , A61F2210/0076 , A61L27/44 , A61L27/507 , A61L27/56
Abstract: In some aspects, graft devices for a mammalian patient can include a tubular member comprising a first end; and a fiber matrix surrounding the tubular member, wherein the fiber matrix is designed and constructed to be substantially continuously tapered at the first end to define a diameter that increases as it approaches the first end.
Abstract translation: 在一些方面,用于哺乳动物患者的移植装置可以包括管状构件,其包括第一端; 以及围绕所述管状构件的纤维基质,其中所述纤维基质被设计和构造成在所述第一端处基本上连续地变细,以限定在其接近所述第一端时增加的直径。
-
公开(公告)号:US20190263068A1
公开(公告)日:2019-08-29
申请号:US16308216
申请日:2017-06-09
Applicant: NEOGRAFT TECHNOLOGIES, INC.
Inventor: Matthew MANNARINO , Jon MCGRATH , Cory LEESON , Mohammed EL-KURDI , Danielle CZARNOWSKI , Kermit SANTIAGO , J. Christopher FLAHERTY
Abstract: A system for producing a graft device for a patient may comprise: an imaging device configured to produce image data of a tubular conduit; and a processing unit configured to receive the image data from the imaging device. The processing unit may comprise an algorithm configured to process the image data, and produce a construction signal based on the image data. A material delivery device may be configured to receive the construction signal from the processor, and deliver material to produce a 3D covering based on the construction signal. The graft device may comprise the 3D covering positioned about the tubular conduit. Graft devices and methods of producing graft devices may also be provided.
-
公开(公告)号:US10239071B2
公开(公告)日:2019-03-26
申请号:US15228339
申请日:2016-08-04
Applicant: Neograft Technologies, Inc.
Inventor: Lorenzo Soletti , Mohammed S. El-Kurdi , Jon McGrath , Andrew Ziegler , J. Christopher Flaherty , William R. Wagner , David Vorp
IPC: B05B5/12 , B05B5/025 , A61F2/07 , A61F2/02 , A61F2/04 , A61F2/06 , A61L27/36 , D01D5/00 , D01D13/02 , A61B90/00
Abstract: A cartridge device is provided for applying a fiber matrix to a tubular member such as a saphenous vein graft. The cartridge includes a housing, a tubular member holder, a rotational drive, and a polymer delivery assembly. The housing defines a chamber which surrounds the tubular member holder. The rotational drive rotates the tubular member during the fiber application process.
-
-
-
-
-
-
-
-
-